cGAS-STING signaling in ischemic diseases

Clin Chim Acta. 2022 Jun 1:531:177-182. doi: 10.1016/j.cca.2022.04.003. Epub 2022 Apr 8.

Abstract

Double stranded DNA (dsDNA) is known to act as a damage-associated molecular pattern (DAMP) that stimulates the body's innate immune response. In general, cyclicGMP-AMP(cGAMP)synthase(cGAS), a DNA sensor, detects these disease-causing DNA and activates the stimulator of interferon gene (STING), which in turn phosphorylates interferon regulatory factor 3 (IRF3), triggering the synthesis of type I interferon (IFN). During this process, the cGAS-STING pathway interacts with different modes of cell death, including autophagy, apoptosis, pyroptosis, and necroptosis. Importantly, cGAS might get stimulated by self-DNA, such as nuclear DNA (nuDNA) and mitochondrial DNA (mtDNA), which ensures a close association between the cGAS-STING signaling pathway and autoimmune responses. Following an ischemic attack, damaged or necrotic cells release large amounts of self-DNA that subsequently activate cGAS, resulting in a range of consequences related to an injury. The present study presents an overview of studies focused on cGAS-STING signaling and cell death, and summarizes the findings of this pathway with regard to ischemia or ischemia/reperfusion (I/R) in different organs of the body, including heart, brain, liver, kidney, and intestine.

Keywords: Cell death; Ischemia; Reperfusion; STING; cGAS.

Publication types

  • Review

MeSH terms

  • DNA, Mitochondrial / genetics
  • Humans
  • Ischemia
  • Membrane Proteins* / genetics
  • Nucleotidyltransferases* / genetics
  • Nucleotidyltransferases* / metabolism
  • Signal Transduction / physiology

Substances

  • DNA, Mitochondrial
  • Membrane Proteins
  • Nucleotidyltransferases